home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Hypermethylation of CpG islands is a common feature in cancer cell lines

  July, 19 2001 15:15
your information resource in human molecular genetics
In the last few years, numerous studies have dealt with the hypermethylation of CpG islands in promoters that is frequently observed in cancer cell lines. Promoter hypermethylation is capable of repressing the expression of genes, a process which may contribute to carcinogenesis especially if the promoters of tumor suppressor genes are affected.

A recent study published in Human Molecular Genetics (Smiraglia et al., Hum. Mol. Genet., 2001, Vol. 10, No. 13, 1413-1419) reveals that the hypermethylation of CpG islands observed in cancer lines seems to be an intrinsic property specific of these cell lines. Using a method called restriction landmark genomic scanning to measure the extent of hypermethylation, the authors could show that cancer cell lines exhibited a significantly higher level of CpG island hypermethylation compared to the primary malignancies from which they originated. Furthermore, 70% of hypermethylated loci were found to be hypermethylated in cancer cell lines of different type. This observation reinforces the idea that hypermethylated loci may be less representative of a special tumor type than of a stage in the establishment of a tumourous phenotype.


Dominic J. Smiraglia
The Ohio State University
Division of Human Cancer Genetics
phone +1 614 292 6478
fax +1 614 688 4761
e-mail Smiraglia.1@postbox.acs.ohio-state.edu

Message posted by: Ulrike Sattler

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.